Steven Cohen Novo Cure LTD Put Options Transaction History

Point72 Asset Management, L.P.

  • $42.2 Billion
  • Q4 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$40.29 - $82.51 $604,350 - $1.24 Million
15,000 New
15,000 $622,000
Q1 2023

May 15, 2023
SELL
$56.44 - $118.81 $8.75 Million - $18.4 Million
-155,000 Closed
0 $0
Q4 2022

Feb 14, 2023
BUY
$63.98 - $85.37 $9.92 Million - $13.2 Million
155,000 New
155,000 $11.4 Million

Others Institutions Holding NVCR

# of Institutions
290
Shares Held
75.2M
Call Options Held
1.81M
Put Options Held
464K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.36B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email